Anne M Summers

Summary

Affiliation: North York General Hospital
Country: Canada

Publications

  1. ncbi Maternal serum screening in Ontario using the triple marker test
    A M Summers
    Clinical Geneticist, Genetics, North York General Hospital, Toronto, Ontario, Canada
    J Med Screen 10:107-11. 2003
  2. ncbi The implications of a false positive second-trimester serum screen for Down syndrome
    Anne M Summers
    Department of Genetics, North York General Hospital, Toronto, Ontario, Canada
    Obstet Gynecol 101:1301-6. 2003
  3. ncbi Triploidy identified through second-trimester serum screening
    Tianhua Huang
    Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Prenat Diagn 25:229-33. 2005
  4. ncbi Maternal serum marker medians in Aboriginal Canadian women
    Tianhua Huang
    Genetics, North York General Hospital, 4001 Leslie Street, Toronto, Ontario, M2K 1E1, Canada
    Prenat Diagn 23:98-100. 2003
  5. ncbi The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening
    Tianhua Huang
    Ontario Maternal Serum Screening Database and Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Am J Obstet Gynecol 193:395-403. 2005
  6. ncbi Accuracy of trisomy 18 screening using the second-trimester triple test
    Chris Meier
    Genetics, North York General Hospital, Toronto, Canada
    Prenat Diagn 23:443-6. 2003
  7. ncbi Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies
    Tianhua Huang
    Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Prenat Diagn 27:1138-42. 2007
  8. ncbi Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes
    David Chitayat
    Prenatal Diagnosis and Medical Genetics Program, Mount Sinai Hospital, University of Toronto, Ontario, Canada
    Am J Obstet Gynecol 187:758-63. 2002
  9. pmc Metabolic syndrome features and risk of neural tube defects
    Joel G Ray
    Department of Medicine, St, Michael s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada
    BMC Pregnancy Childbirth 7:21. 2007
  10. doi Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center
    Nanette Okun
    Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Prenat Diagn 28:987-92. 2008

Collaborators

Detail Information

Publications22

  1. ncbi Maternal serum screening in Ontario using the triple marker test
    A M Summers
    Clinical Geneticist, Genetics, North York General Hospital, Toronto, Ontario, Canada
    J Med Screen 10:107-11. 2003
    ..To summarise the experience and evaluate the performance of the Ontario maternal serum screening (MSS) programme...
  2. ncbi The implications of a false positive second-trimester serum screen for Down syndrome
    Anne M Summers
    Department of Genetics, North York General Hospital, Toronto, Ontario, Canada
    Obstet Gynecol 101:1301-6. 2003
    ..To investigate the genetic and obstetric implications of false positive Down syndrome serum screening results...
  3. ncbi Triploidy identified through second-trimester serum screening
    Tianhua Huang
    Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Prenat Diagn 25:229-33. 2005
    ..To describe the maternal serum marker patterns of triploid pregnancies and estimate the second-trimester prevalence of triploidy...
  4. ncbi Maternal serum marker medians in Aboriginal Canadian women
    Tianhua Huang
    Genetics, North York General Hospital, 4001 Leslie Street, Toronto, Ontario, M2K 1E1, Canada
    Prenat Diagn 23:98-100. 2003
    ....
  5. ncbi The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening
    Tianhua Huang
    Ontario Maternal Serum Screening Database and Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Am J Obstet Gynecol 193:395-403. 2005
    ..The purpose of this study was to investigate associations between risk of spontaneous fetal loss and risk estimates for Down syndrome, trisomy 18, and neural tube defects assigned by second-trimester maternal serum screening...
  6. ncbi Accuracy of trisomy 18 screening using the second-trimester triple test
    Chris Meier
    Genetics, North York General Hospital, Toronto, Canada
    Prenat Diagn 23:443-6. 2003
    ..To assess the accuracy of the calculated risk for trisomy 18 assigned to individual women screened with the second-trimester triple test...
  7. ncbi Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies
    Tianhua Huang
    Genetics Program, North York General Hospital, Toronto, Ontario, Canada
    Prenat Diagn 27:1138-42. 2007
    ..To investigate the association of Down syndrome screening results in successive pregnancies, and assess the impacts of including previous screening results in the current risk estimation on screening performance...
  8. ncbi Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes
    David Chitayat
    Prenatal Diagnosis and Medical Genetics Program, Mount Sinai Hospital, University of Toronto, Ontario, Canada
    Am J Obstet Gynecol 187:758-63. 2002
    ..The study was designed to evaluate whether double positive maternal serum screening results for Down syndrome and open neural tube defects indicate an increased risk of adverse perinatal outcome...
  9. pmc Metabolic syndrome features and risk of neural tube defects
    Joel G Ray
    Department of Medicine, St, Michael s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada
    BMC Pregnancy Childbirth 7:21. 2007
    ..Whether they, in combination with additional features of MetSyn, alter this risk is not known. We evaluated the risk of NTD in association with maternal features of the MetSyn...
  10. doi Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center
    Nanette Okun
    Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Prenat Diagn 28:987-92. 2008
    ..To evaluate the performance of integrated prenatal screening (IPS) and first trimester combined screening (FTS) for trisomy 21 in a large Canadian urban center...
  11. ncbi Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay
    Dorota A Kwasnicka-Crawford
    Department of Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Genomics 86:182-94. 2005
    ..The ATP13A4 gene was shown to comprise a 3591-bp transcript encompassing 30 exons spanning 152 kb of the genomic DNA. This study discusses the characterization of ATP13A4 and its possible involvement in speech-language disorder...
  12. doi Euchromatic 9q13-q21 duplication variants are tandem segmental amplifications of sequence reciprocal to 9q13-q21 deletions
    Ann M Joseph-George
    The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada
    J Med Genet 48:317-22. 2011
    ..The molecular characterisation of three of these four variants has been reported. In this study, the genomic structure of the fourth variant, an additional G-positive band at 9q13-q21, is characterised...
  13. pmc Human chromosome 7: DNA sequence and biology
    Stephen W Scherer
    Department of Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8
    Science 300:767-72. 2003
    ..This approach enabled the discovery of candidate genes for developmental diseases including autism...
  14. ncbi Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18
    Anne M Summers
    Prenat Diagn 22:269-71. 2002
  15. ncbi Racial differences in first trimester nuchal translucency
    Tianhua Huang
    Prenat Diagn 27:1174-6. 2007
  16. ncbi Accuracy of expected risk of Down syndrome using the second-trimester triple test
    Chris Meier
    Clin Chem 48:653-5. 2002
  17. ncbi Prenatal screening for fetal aneuploidy
    Anne M Summers
    J Obstet Gynaecol Can 29:146-79. 2007
    ..To develop a Canadian consensus document with recommendations on maternal screening for fetal aneuploidy(e.g., Down syndrome and trisomy 18) in pregnancy...
  18. ncbi Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study
    Glenn E Palomaki
    Women and Infants Hospital, Providence, Rhode Island 02903, USA
    Prenat Diagn 26:730-9. 2006
    ..To confirm that measuring pregnancy-associated plasma protein-A (PAPP-A) in both first- and second-trimester serum samples improves Down syndrome screening...
  19. ncbi Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics
    Sau W Cheung
    Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030
    Am J Med Genet A 143:1679-86. 2007
    ..This suggests that aCGH may detect somatic chromosomal mosaicism that would be missed by conventional cytogenetics...
  20. ncbi Bibliography. Current awareness in prenatal diagnosis
    Anne M Summers
    Prenat Diagn 22:272-8. 2002
  21. ncbi Contingent screening for Down syndrome
    Anne M Summers
    Prenat Diagn 25:963. 2005
  22. ncbi Should more ethnicity categories be used in multiple marker screening programmes?
    Richard Liu
    Prenat Diagn 24:479-80. 2004